ArticleTurkish journal of medical sciences2026
Hounsfield unit thresholds in differentiating adenoma from nonadenoma adrenal masses: a retrospective adrenalectomy-based study.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: Adrenal incidentalomas are increasingly detected during imaging studies performed for various indications, and their frequency in endocrinology practice has risen in recent years. While adenomas account for approximately 80% of adrenal incidentalomas, the remaining 20% include lesions such as primary malignancies, metastases, and pheochromocytomas that should not be overlooked. Given the risks associated with adrenal biopsy, accurate diagnosis with noninvasive methods is essential. In this retrospective study, we evaluated the Hounsfield unit (HU) values and lesion sizes measured on noncontrast computed tomography (CT) to identify a more accurate threshold than the widely used 10 HU. Materials and methods: In this retrospective study, patients who underwent unilateral adrenalectomy between 2013 and 2022 were evaluated. Noncontrast CT images were assessed for lesion size and attenuation, and statistical analyses included tests for nonnormally distributed data, logistic regression, and ROC analysis to determine the diagnostic performance of mass size and density in differentiating adenoma from nonadenoma lesions. Results: A total of 106 patients who underwent adrenalectomy for various indications were included, of whom 55 had adenomas and 51 had nonadenoma masses. The mean size of the adenoma versus nonadenoma lesions was 37.2 ± 15 mm and 55.8 ± 30 mm, respectively (p < 0.05), while mean HU values were 11.4 ± 17 and 35.9 ± 14, respectively (p < 0.05). The ROC analysis showed that HU values exhibited strong discriminative ability in distinguishing adenoma from nonadenoma masses (AUC = 0.869). According to Youden's index, 20 HU was identified as the optimal threshold value. The sensitivity/specificity values for 10 HU, 15 HU, and 20 HU were 98%/56%, 98%/61%, and 92%/82%, respectively. Conclusion: Within this selected adrenalectomy cohort, adopting a 20 HU threshold instead of the conventional 10 HU value significantly improved specificity in differentiating adenomas from nonadenomas. However, broader prospective validation in unselected incidentaloma populations is warranted before recommending a definitive change in routine clinical guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.